Drug intelligence / Profile preview

Nepisond

Development stage
Preclinical
Lead developer
San Giuseppe Moscati
Modality
Recombinant Proteins and Enzymes, Peptides, Small Molecules
Administration
Oral
01

Overview

**Nepisond** is an Italian specialized very-low-calorie, protein-based enteral nutrition formula used within a short-course protein-sparing modified fast protocol for severe obesity. The formula uses milk whey protein plus free amino acids including arginine, ornithine-alpha-ketoglutarate, taurine, cysteine, tryptophan, hydroxyproline, and citrulline, with linseed oil, L-carnitine, coenzyme Q10, policosanols, fructooligosaccharides, and electrolyte supplementation. It is delivered continuously through a nasogastric tube for approximately 14 days to maintain protein intake while inducing nutritional ketosis and marked caloric restriction. In a 364-patient study, this approach was associated with short-term weight loss and improvements in glycemic, lipid, and blood-pressure measures, although hyperuricemia and transient aminotransferase elevations occurred. ([ncbi.nlm.nih.gov](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438151/))

Brand names
Nepisond

Beyond the preview

Go deeper on Nepisond.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nepisond.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call